US20050228359A1 - Method and apparatus for treating acute stroke - Google Patents
Method and apparatus for treating acute stroke Download PDFInfo
- Publication number
- US20050228359A1 US20050228359A1 US11/098,088 US9808805A US2005228359A1 US 20050228359 A1 US20050228359 A1 US 20050228359A1 US 9808805 A US9808805 A US 9808805A US 2005228359 A1 US2005228359 A1 US 2005228359A1
- Authority
- US
- United States
- Prior art keywords
- fluid
- artery
- catheter
- carotid artery
- opening
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M2025/1043—Balloon catheters with special features or adapted for special applications
- A61M2025/1052—Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Pulmonology (AREA)
- Child & Adolescent Psychology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
Abstract
The invention provides a method and system for introducing cool fluid to a targeted treatment site, such as, for example, a stroke-affected brain hemisphere. In one approach, the method generally includes introducing a catheter into a branch artery of the external carotid artery, and introducing fluid into the ipsilateral internal carotid artery. In one approach, a balloon is used to occlude the external carotid artery during introduction of the fluid into the internal carotid artery.
Description
- This application claims the benefit of U.S. Provisional Application No. 60/560,202, filed Apr. 7, 2004, the contents of which are incorporated in their entirety herein by reference.
- 1. Field of the Invention
- The present invention relates generally to the treatment of ischemic organs, such as the brain in the setting of transient ischemic attack (TIA) or stroke, and more specifically to methods and apparatus for delivering a cool fluid to the vascular territory of brain regions that are experiencing ischemia and/or acute stroke.
- 2. Description of the Related Art
- Stroke is the third leading cause of death in the United States and is the leading disabling neurological disorder. A stroke or cerebrovascular accident (CVA) refers to a situation in which the blood supply to a brain region is interrupted by occlusion (an ischemic stroke) or by hemorrhage (a hemorrhagic stroke). A hemorrhagic stroke occurs when a blood vessel in the brain, an arteriovenous malformation, or a cerebral aneurysm ruptures, spilling blood into the spaces surrounding the brain cells.
- Approximately 700,000 patients suffer from stroke annually. Stroke is a syndrome characterized by the acute onset of a neurological deficit that persists for at least 24 hours, reflecting focal involvement of the central nervous system, and is the result of a disturbance of the cerebral circulation. When a patient presents with neurological symptoms and signs which resolve completely within 1 hour, the term transient ischemic attack (TIA) is used. Etiologically, TIA and stroke share the same pathophysiologic mechanisms and thus represent a continuum based on persistence of symptoms and extent of ischemic insult.
- Outcome following stroke is influenced by a number of factors, the most important being the nature and severity of the resulting neurologic deficit. Overall, less than 80% of patients with stroke survive for at least 1 month, and approximately 35% have been cited for the 10-year survival rates. Of patients who survive the acute period, up to 75% regain independent function, while approximately 15% require institutional care.
- Hemorrhagic stroke accounts for 20% of the annual stroke population. Hemorrhagic stroke often occurs due to rupture of an aneurysm or arteriovenous malformation bleeding into the brain tissue, resulting in cerebral infarction. The remaining 80% of the stroke population are hemispheric ischemic strokes and are caused by occluded vessels that deprive the brain of oxygen-carrying blood. Ischemic strokes are often caused by emboli or pieces of thrombotic tissue that have dislodged from other body sites or from the cerebral vessels themselves to occlude in the narrow cerebral arteries more distally. The internal carotid artery, commonly affected by atherosclerosis causing symptomatic occlusion in the arterial lumen, is often responsible for hemispheric ischemic stroke and generating thromboembolic material downstream to the distal cerebral vessels. Treatment of the occluded carotid artery in patients with stroke and TIA or for stroke prevention in patients with asymptomatic flow limiting carotid stenosis undergoing major cardiothoracic surgeries includes performing angioplasty, stent placement, or atherectomy on the occluded carotid artery. Unfortunately, placing instrumentation within a diseased carotid artery is associated with increased risk of ischemic stroke, since manipulation of an atheromatous plaque in the arterial wall often causes emboli to dislodge distally in the narrow cerebral arteries.
- There are generally three treatment stages for stroke: (1) prevention; (2) therapy immediately after stroke; and (3) post-stroke rehabilitation. Therapies to prevent stroke are based on treating underlying risk factors. Acute stroke therapies try to stop a stroke while it is happening. Post-stroke rehabilitation is to overcome disabilities that result from stroke damage. While advances have been made in the area of acute stroke therapies (i.e., treatment stage 2), there exists a need for devices and methods for reducing the effect of strokes when they occur.
- One acute stroke therapy involves inducing hypothermia of the body to protect the brain from injury. Hypothermia is believed to lower the metabolic demands in the penumbral area surrounding the necrotic or apoptotic core of the infarct. Cooling of the brain can be accomplished through whole body cooling to create a condition of total body hypothermia in the range of about 20° C. to about 30° C. Another acute stroke therapy involves inducing hypothermia of the head to protect the brain. For example, some physicians have immersed the patient's head in ice, or have used cooling helmets or head gear to achieve the same. It has been shown, however, that complications (e.g., arrhythmias and decreased cardiac output) can arise from total body cooling or cooling of the face and head only.
- Selective organ hypothermia is a promising acute stroke therapy, and involves perfusing the targeted organ with a cold solution, such as saline or perflourocarbons. Challenges with this mode of therapy include avoiding excessive volume accumulation, temperature dilution by blood, and damage to tissue and vessels, particularly near the already traumatized targeted organ. There exists a need for a treatment that can be implemented soon after the onset of a stroke episode to salvage the brain cells surrounding the damaged brain cells.
- In accordance with one aspect of the embodiments described herein, there is provided a method of introducing cool fluid to a targeted treatment site. In one application, the treatment site comprises a stroke-affected brain hemisphere. In one approach, the method generally comprises: introducing a catheter into an opening in a branch artery of the external carotid artery that is ipsilateral to the hemisphere; advancing the catheter from the opening in the branch artery along the branch artery in a direction retrograde to physiologic blood flow; positioning an opening in said catheter at the bifurcation of the ipsilateral internal and external carotid arteries; and while temporarily occluding the external carotid artery, introducing fluid through the opening in said catheter such that the fluid flows into the ipsilateral internal carotid artery in a direction antegrade to physiologic blood flow.
- In accordance with one aspect of the embodiments described herein, there is provided a method of introducing cool fluid to a targeted treatment site. In one application, the treatment site comprises a stroke-affected brain hemisphere. In one approach, the method generally comprises: introducing a catheter into an opening in a branch artery of the external carotid artery that is ipsilateral to the hemisphere; advancing said catheter from the opening in the branch artery along the branch artery in a direction retrograde to physiologic blood flow; positioning an opening in said catheter within the external carotid artery; and introducing fluid through the opening in said catheter such that the fluid flows in the external carotid artery in a direction retrograde to physiologic blood flow and then flows into the ipsilateral internal carotid artery in a direction antegrade to physiologic blood flow.
- In accordance with one aspect of the embodiments described herein, there is provided a system for delivering cool fluid to a targeted treatment site. In some embodiments, the treatment site comprises a stroke-affected and/or ischemic brain region.
- In some embodiments, the system generally comprises a catheter configured for use in the vessels of the head and neck regions, where the catheter extending between from a proximal end to a distal end, where the catheter comprises an inner lumen and a distally-located opening that is in communication with the lumen. The system further comprises a supply of cool fluid connected to the lumen near the catheter distal end for delivering cool fluid to a targeted vascular region. In some embodiments, the cool fluid comprises cold crystalloid solution.
- In some embodiments, the system generally comprises a flexible, elongate catheter, the catheter having a proximal end and a distal end, the catheter comprising a lumen and a distal opening that is in communication with the lumen; a counterpulsation balloon mounted at or near the catheter's distal end; a controller in communication with the counterpulsation balloon, the controller configured to produce delivery of a quantity of a fluid through the catheter when the counterpulsation balloon is primarily in an inflation mode, the controller further configured to decrease or cease the delivery of the fluid through the catheter when the counterpulsation balloon is primarily in a deflation mode.
- In some embodiments, the catheter is configured to be positioned in an external carotid artery of a human. Some embodiments further comprise a receptacle configured to supply the fluid to the catheter. In some embodiments, the supply comprises a refrigeration system configured to keep the fluid below 30° C.
- In some embodiments, the system further comprises a counterpulsation balloon mounted near the catheter distal end, and a counterpulsation controller that is communication with the balloon.
-
FIG. 1 illustrates various great vessels of the systemic circulatory system. -
FIG. 2 depicts normal cerebral circulation in the Circle of Willis. -
FIG. 3 is a schematic representation of human head displaying the main arteries that branch from the external carotid artery and that supply blood to the head, face, and neck area. -
FIG. 4 is a schematic representation of a common carotid artery in the head and neck of a patient. -
FIG. 5 is a schematic representation of the branching of the external and internal carotid arties. -
FIG. 6A illustrates a method of introducing cool fluid by positioning a small vessel catheter at the bifurcation of the common carotid artery into the external and internal carotid arteries. -
FIG. 6B illustrates a method of introducing cool fluid by positioning a small vessel catheter in the external carotid artery. -
FIG. 7A illustrates a method of introducing cool fluid by positioning a balloon catheter assembly at the bifurcation of the common carotid artery into the external and internal carotid arteries. -
FIG. 7B illustrates a method of introducing cool fluid by positioning a balloon catheter in the external carotid artery. -
FIG. 8 depicts one embodiment of a system for delivering cool fluid to a stroke-affected brain hemisphere. -
FIG. 9 is a cross-sectional view of the catheter of the system inFIG. 8 . - With reference to
FIG. 1 , oxygenated blood from the heart normally flows upwardly through the aortic arch and then downward to the lower portions of the body through the thoracic aorta. Three major arteries extend upwardly from the top of the aortic arch. The brachiocephalic, or inominate, artery branches into the right carotid artery and the right subclavian artery. In contrast, the left carotid artery and left subclavian artery extend directly from the aortic arch and do not have a common portion. Along with the vertebral arteries, the right and left common carotid arteries provide oxygenated blood to most parts of the head and neck. They ascend through the anterior neck just lateral to the trachea and are covered by relatively thin muscles. In addition to the carotid arteries, oxygenated blood is provided to the brain through the vertebral arteries, although to a significantly lesser extent. - As
FIG. 2 further illustratesaorta 100 gives rise to rightbrachiocephalic trunk 82, left common carotid artery (CCA) 80 L, and leftsubclavian artery 84. The brachiocephalic artery further branches into right commoncarotid artery 80 R and rightsubclavian artery 83. The left CCA gives rise to left internal carotid artery (ICA) 90 L which becomes left middle cerebral artery (MCA) 97 and left anterior cerebral artery (ACA) 99. Anteriorly, the Circle of Willis is formed by the internal carotid arteries, the anterior cerebral arteries, and anterior communicatingartery 91 which connects the two ACAs. The right and left ICA also send rightposterior communicating artery 72 and left posterior communicatingartery 95 to connect respectively with right posterior cerebral artery (PCA) 74 and leftPCA 94. The two posterior communicating arteries and PCAs, and the origin of the posterior cerebral frombasilar artery 92 complete the circle posteriorly. The left CCA also gives rise to external carotid artery (ECA) 47 L, which branches extensively to supply most of the structures of the head except the brain and the contents of the orbit. The ECA also helps supply structures in the neck. - The cerebral circulation is regulated in such a way that a constant total cerebral blood flow (CBF) is generally maintained under varying conditions. For example, a reduction in flow to one part of the brain, such as in stroke, may be compensated by an increase in flow to another part, so that CBF to any one region of the brain remains unchanged. Also, when one part of the brain becomes ischemic due to a vascular occlusion, the brain compensates by increasing blood flow to the ischemic area through its collateral circulation via the Circle of Willis.
- The internal carotid artery supplies the anterior part of the brain, the eye and its appendages, and sends branches to the forehead and nose. The external carotid artery begins opposite the upper border of the thyroid cartilage, and, taking a slightly curved course, passes upward and forward, and then inclines backward to the space behind the neck of the mandible, where it divides into the superficial temporal and internal maxillary arteries.
- As illustrated in
FIG. 2 , the internalcarotid arteries - The external carotid artery usually has eight branches in the neck: superior thyroid artery, lingual artery, facial artery, ascending pharyngeal artery, occipital artery, posterior auricular artery, maxillary artery, and superficial temporal artery. The latter two could be considered a terminal bifurcation of the artery; the maxillary artery is the larger of the two.
-
FIG. 3 graphically depicts the network arteries branching from the externalcarotid artery 47 within the head. Superimposed upon this view are the spatial divisions of the human head. The posterior division F includes the back of the neck and extends upwardly behind the ear, as encompassed by the dashedlines 40 and 41. The ophthalmic area G, lying above the dashedlines 41 and 42, includes the top and frontal area of the scalp and head. The superficial cervical plexus H, defined by the dashedline 40 at the rear and the dashedline 43 at the front, includes the front and sides of the neck, the underside of the chin and diverges upwardly to include the ear. The mandibular area I, lying above the dashedline 43 and below the dashed line 44, generally includes the lower jaw and the temple area and extends upwardly to the ophthalmic area G. The maxillary area J, lying between the mandibular area I and the ophthalmic area G as defined by the dashedlines 44 and 42, respectively, generally includes the upper jaw and a narrow upward extension lying between the temple and the eye. - The external
carotid artery 47 supplies the superficial parts of the head, face and neck. Theoccipital artery 48 is the first branch of the externalcarotid artery 47 as it delivers blood in the direction of the arrow K from the heart to the head. Theoccipital artery 48 supplies the scalp and the back of the head within the lower portion of the posterior division F. Thesternocleidomastoid artery 49 branches from the occipital artery to deliver blood within the superficial cervical plexus H below and behind the ear. The superficialtemporal artery 50 is an extension of the externalcarotid artery 47 which extends upwardly immediately in front of the ear. Immediately above the ear, the superficialtemporal artery 50 subdivides into two primary branches: a first branch, the posteriortemporal branch 51, which supplies the rearward portion of the ophthalmic area G and the upper portion of the posterior division F, and the anterior temporal branch 52 which supplies blood to the upper frontal portion of the ophthalmic area G. The superficialtemporal artery 50 and the lower portion of the posterior temporal 51 and the lower portion of the anterior temporal 52 also supply blood to the upper portion of the mandibular area I and the maxillary area J. - With reference to
FIGS. 3 and 4 , at approximately the level of the third cervical vertebra, the common carotid 80 branches into the internalcarotid artery 90 and the externalcarotid artery 47. The externalcarotid artery 47 branches into numerous arteries in the head regions, including, for example, the externaloccipital artery 48 and the superficialtemporal artery 50.FIG. 5 provides a schematic representation of the branching of the commoncarotid artery 80 into externalcarotid artery 47 and the internalcarotid artery 90 at the junction orbifurcation 110. - As explained above, one promising acute stroke therapy involves perfusing the blood-deprived brain region with a cool solution to induce hypothermia in the brain region, thereby mitigating the effect of the stroke in the brain region. Disclosed herein is a method of selectively inducing hypothermia in the brain hemisphere where the stroke has occurred.
- In accordance with one aspect of the embodiments described herein, there is provided a method for treating stroke by introducing cooled fluid into the a brain hemisphere that has been blood-deprived as a result of the stroke. In one approach, the method for introducing cooled fluid generally comprises: introducing a catheter into a branch artery of the external carotid artery that is ipsilateral to the brain hemisphere; advancing the catheter along the branch artery in a direction retrograde to physiological blood flow; and introducing cool fluid through the catheter opening such that the fluid flows into the ipsilateral internal carotid artery in a direction antegrade to physiologic blood flow.
- Short of placing a catheter dripping cold crystalloid solution directly in the vascular territory of an infarct associated with a CVA, one preferred approach involves placing a catheter in the external carotid artery at the bifurcation of the internal carotid artery, and infusing a cool fluid (e.g., cooled saline) through the internal carotid ipsilateral to the CVA.
- With reference to
FIGS. 3 and 4 , in one exemplary approach, the externalcarotid artery 47 is accessed through the superficialtemporal artery 50. In another exemplary approach, the external carotid artery is accessed through the externaloccipital artery 48, particularly if there is a concern about a superficial temporal artery/middle cerebral artery anastomosis or potential bypass. Either of thesevessels - With reference to
FIG. 6A , in one approach, a percutaneouslyinsertable catheter 120 is introduced in any known suitable branch artery of the externalcarotid artery 47 that is ipsilateral to the stroke-affected brain hemisphere. Suitable branch arteries include, for example, theoccipital artery 48, thesternocleidomastoid artery 49, the superficialtemporal artery 50, the posteriortemporal branch 51, the anterior temporal branch 52, etc. In another approach, the 120 is introduced in the lower branch of the externalcarotid artery 47, closer to thebifurcation 110 of the ipsilateral external and internalcarotid arteries - After the external
carotid artery 47 has been catheterized, thecatheter 120 is the advanced toward thebifurcation 110 of the ipsilateral external and internalcarotid arteries catheter 120 is positioned so that the catheter distal end 122, along with the catheter opening 124 near the distal end 122, is at or near thebifurcation 110. Thecatheter 120 is preferably advanced and positioned using any known suitable visualization technique, such as, for example, ultrasound imaging, fluoroscopy, radiography, etc. - With continued reference to
FIG. 6A , in one approach, the catheter distal end 122 is positioned at thebifurcation 110. After thecatheter 120 has been positioned near thebifurcation 110, acool fluid 130 is introduced through the catheter opening 124 and into the ipsilateral internalcarotid artery 90 in a direction antegrade to physiologic blood flow, thereby deliveringcool fluid 130 to stroke-affected regions in the ipsilateral brain hemisphere. - Because only the ipsilateral hemisphere is being cooled, a reduced volume of cool fluid is needed to cool the targeted hemisphere, thereby resulting in reduced global or whole body cooling. Global cooling is also reduced due to the second pass of the infused cool fluid through the cardiopulmonary circulation.
- With reference to
FIG. 6B , in one approach, thecatheter 120 is introduced into a branch of the externalcarotid artery 47 and advanced toward but just short of thebifurcation 110, leaving a short distance between the catheter distal end 122 and thebifurcation 110. After the distal end 122 has been positioned near thebifurcation 110, acool fluid 130 is introduced through the catheter opening, 124 and into the externalcarotid artery 47 in a direction retrograde to physiologic blood flow. Thecool fluid 130 is preferably pushed or pumped into externalcarotid artery 47 with enough pressure to overcome the blood pressure in the externalcarotid artery 47, so that thecool fluid 130 is redirected into ipsilateral internalcarotid artery 90 in a direction antegrade to physiologic blood flow, thereby deliveringcool fluid 130 to stroke-affected regions in the ipsilateral brain hemisphere. - In another approach, the
catheter 120 is introduced into a branch of the externalcarotid artery 47 and advanced beyond thebifurcation 110. After the distal end 122 has been positioned beyond thebifurcation 110, acool fluid 130 is introduced through the catheter opening 124, and into ipsilateral internalcarotid artery 90 in a direction antegrade to physiologic blood flow, thereby deliveringcool fluid 130 to stroke-affected regions in the ipsilateral brain hemisphere. - In one approach, the
cool fluid 130 comprises normal saline that is cooler than the patient's body temperature. In some approaches, the fluid 130 has a temperature in the range of about 0° C. to about 30° C. In some approaches, the fluid 130 has a temperature of about 5° C. to about 20° C. - In one exemplary approach, the fluid 130 comprises isosmolar crystalloid or colloid solution, such as iced saline. In another approach, the fluid 130 comprises a mixture of cool saline and a stroke-treating medication, such as an antithrombotic, anticoagulant, thrombolytic, or antiplatelet drug.
- In accordance with one aspect of the embodiments described herein, there is provided a method of delivering cool fluid to a stroke-affected or ischemic brain hemisphere, comprising: introducing a catheter assembly into a branch artery of the external carotid artery that is ipsilateral to the affected brain hemisphere; advancing the assembly along the branch artery in a direction retrograde to physiological blood flow; positioning an opening in the assembly at the bifurcation of the ipsilateral internal and external carotid arteries; and while temporarily occluding the external carotid artery, introducing cool fluid through the opening such that the fluid flows into the ipsilateral internal carotid artery in a direction antegrade to physiologic blood flow.
- As explained below, in one approach, washout of the cool fluid can be prevented by a synchronized counterpulsation balloon that blocks the external carotid as the saline cycles at a rate that is matched or close to the patient's cardiac cycle (e.g., 30-60 times a second). With enough pressure from the infuser pump, it is possible for the infused cool fluid to overcome the blood pressure near the common carotid artery bifurcation and circulate through the internal carotid artery, and thus to the vascular territory of the infarction. Deflation of the balloon results in the reestablishment of blood flow up through the external carotid artery, thereby washing up any clot formation that may occur. Clot reduction can also be reduced through the use of a known suitable medication that prevents the formation of clots (e.g., carefully administered doses of heparin).
- With reference to
FIG. 7A , in one approach, aballoon catheter assembly 140 is percutaneously introduced into a branch of the externalcarotid artery 47 and advanced toward but just short of thebifurcation 110, leaving a short distance between the catheterdistal end 142 and thebifurcation 110. After thedistal end 142 has been positioned at or near thebifurcation 110, the externalcarotid artery 47 is temporarily occluded by distally expanding theballoon 146 of thecatheter assembly 140, thereby temporarily blocking blood flow through the externalcarotid artery 47. In one approach, expansion of theballoon 146 partially, temporarily blocks blood flow throughartery 47. In another approach, expansion of theballoon 146 completely, temporarily blocks blood flow throughartery 47. - With continued reference to
FIGS. 7A and 7B , while temporarily occluding blood flow through the externalcarotid artery 47, acool fluid 130 is introduced through thecatheter opening 144, and into the externalcarotid artery 47 in a direction toward thebifurcation 110 and into ipsilateral internalcarotid artery 90 in a direction antegrade to physiologic blood flow, thereby deliveringcool fluid 130 to stroke-affected regions in the ipsilateral brain hemisphere. Because expansion of theballoon 146 occludes blood flow in the externalcarotid artery 47, less pressure is required to pushcool fluid 130 into the ipsilateral internalcarotid artery 90. - The
distal end 142 of thecatheter assembly 140 can be placed at number of suitable positions near thebifurcation 110. In one approach, shown inFIG. 7A , the catheterdistal end 142 is positioned at thebifurcation 110. In another approach, shown inFIG. 7B , the catheterdistal end 142 is positioned within the externalcarotid artery 47. In yet another approach, the catheterdistal end 142 is positioned beyond thebifurcation 110. As explained below, for each of the approaches inflation of theballoon 146 and introduction ofcool fluid 130 at or near thebifurcation 110 occurs during diastole, so that the fluid 130 enters the internalcarotid artery 90. - In one approach, the
balloon 146 is phasically pulsed in counterpulsation to the patient's cardiac cycle. Thecatheter assembly 140 is connected acontroller 160 that receives the patient's electrocardiogram (ECG). In response to the ECG signal, thecontroller 160 causes theballoon 146 to be inflated during diastole (when the heart muscle is relaxed) and deflated during isometric contraction or early systole.Cool fluid 130 is introduced through thecatheter opening 144 during diastole, when theballoon 146 is inflated, which facilitates delivery of thecool fluid 130 into the ipsilateral internalcarotid artery 90. Thecool fluid 130 is introduced at the bifurcation of the external and internalcarotid arteries balloon 146 blocks entry into the externalcarotid artery 47, blood from the commoncarotid artery 80 andcool fluid 130 from thecatheter opening 144 are shunted into the internalcarotid artery 90. - In accordance with one aspect of the embodiments described herein, there is provided a system for delivering cool fluid to a stroke-affected brain hemisphere. In some embodiments, the system comprises a flexible, elongate catheter extending between a proximal end and a distal end, a counterpulsation balloon mounted near the catheter distal end, a counterpulsation controller that is in communication with the balloon, and a supply of cool fluid connected to the catheter proximal end.
- With reference to
FIGS. 8 and 9 , in some embodiments, thesystem 150 for deliveringcool fluid 130 to a stroke-affected brain hemisphere comprises acatheter assembly 140, which comprises asmall vessel catheter 141 and acounterpulsation balloon 146. Thesmall vessel catheter 141 comprises an elongate, flexible, tubular body 145 that extends from aproximal end 143 to adistal end 142. Thecatheter 141 comprises acool fluid lumen 149 that extends from theproximal end 143 to thedistal end 142, and that is in communication with acatheter opening 144 near thedistal end 142. Thecatheter 141 comprises aninflation lumen 147 and one or more port(s) 148 that allow communication between thelumen 147 and the inside of theballoon 146. Thesmall vessel catheter 141 is dimensioned for use in the targeted vascular region. In one application, the targeted vascular region comprises the smaller vessels of the patient's body, such as, for example, the arteries which supply blood from the heart to the head, face, and neck areas. - The tubular body 145 and other components of the
catheter 141 can be manufactured in accordance with any of a variety of techniques known in the catheter manufacturing field. Suitable material dimensions can be readily selected taking into account the natural and anatomical dimensions of the treatment site and of the desired percutaneous access site. Thecatheter 141 is preferably constructed from a biocompatible and flexible material (e.g., polyurethane, polyvinyl chloride, polyethylene, nylon, etc.). In one exemplary embodiment, thecatheter 141 is 5 F and about 100 cm to about 200 cm in length to facilitate placement in the cerebral vasculature. Examples of suitable small vessel catheters can be found in U.S. Pat. No. 4,995,862, issued Sep. 11, 1990, titled CATHETER AND CATHETER/GUIDE WIRE DEVICE, the content of which is incorporated in its entirety herein by reference. The actual dimensions of a device constructed according to the principles of the embodiments described herein can vary outside of the any ranges listed herein without departing from the principles. - Preferably, the gas used to inflate the
balloon 146 is carbon dioxide (which has fewer consequences in the rare event of a balloon bursting), helium (which has the fastest ability to travel or diffuse), or the like. - With continued reference to
FIG. 8 , thecounterpulsation balloon 146 is any suitable expandable member and is similar to the balloon of an intra-aortic balloon pump (IABP) that has been adapted for use in vessels that supply blood to the head and neck regions. Thecounterpulsation balloon 146 is connected to an IABP-type,counterpulsation pump 160 which pumps an inflation fluid 162 (e.g., helium, carbon dioxide, etc.) into and out of thecounterpulsation balloon 146 at specific times in relation to cardiac cycle of the patient. - The
balloon 146 can be of the same material as currently in use in intra-aortic balloon pumps. Theballoon 146 can be formed by dip molding on an appropriately shaped mandrel, with a hydrophilic coating. One specific commercially available polyurethane which has proven satisfactory in such balloons, including those used in practicing this invention, is sold by B.F. Goodrich under the designation Estane 58810. Theballoon 146 is preferably made by dip casting on a mandrel having a shape corresponding to the inflated unstretched shape of the balloon. The dipping speed and time are adjusted to produce thin-walled balloons. - The bond between the
balloon 146 and thecatheter 141 is preferably airtight and effected in a manner to minimize the diametral dimension build-up of thecatheter assembly 140. In some embodiments,balloon 146 and thecatheter 141 are attached to each other via pressure-bonding with radiofrequency heating to a temperature approximating the melting temperature of the materials to enhance the bond and provide even greater control and to minimize the final outer dimensions in these bonding areas. - With continued reference to
FIG. 8 , acontrol apparatus 164 is connected to the counterpulsation pump/controller 160. Thecontroller apparatus 164 drives and controls thecounterpulsation pump 160, which in turn determine adjusts the inflation/deflation state ofballoon 146. Thecontrol apparatus 164 typically comprises a logic computer system that receives data on the patient's ECG signal, arterial waveform, and/or an intrinsic pump rate, and that adjusts the counterpulsation pump rate on this data. In some embodiments, the inflation phase of thecontrol apparatus 164 is triggered by the R wave of the patient's ECG signal. Balloon inflation is typically set to start in the middle of the T wave and to deflate prior to the ending QRS complex. It will be understood, however, that thecontrol apparatus 164 can be selected and adjusted in any known suitable manner to achieve inflation of theballoon 146 during diastole and deflation during systole, or with an appropriate delay to cause fluid injection through a catheter to coincide with run-off of blood flow in a carotid or other artery - Because peripheral temperature measurements are often not accurate indicators of temperatures at particular locations, such as the CVA-affected brain hemisphere, it can be advantageous to implement temperature probes into the
system 150. With continued reference toFIG. 8 , in some embodiments, thesystem 150 comprises atemperature probe 166 placed in or near the affected hemisphere. Theprobe 166 is in communication with thecontrol apparatus 164. Theprobe 166 can comprise any known suitable temperature monitoring device, such as, for example, a digital thermometer. - In some embodiments, the
system 150 comprises acontrol apparatus 164 that performs intra-carotid-artery counterpulsation concurrently with the inducement/maintenance of hypothermia, the specifics of which are described in U.S. Pat. No. 6,800,068, issued Oct. 4, 2004, titled INTRA-AORTIC BALLOON COUNTERPULSATION WITH CONCURRENT HYPOTHERMIA, the content of which is incorporated in its entirety herein by reference. - A
supply 170 ofcool fluid 130 is attached to the distal end of thecool fluid lumen 149, and stores thecool fluid 130 that is pumped through thelumen 149, through theopening 144, and ultimately into the internalcarotid artery 90. As explained above, in some embodiments, thecool fluid 130 comprises cold crystalloid solution. Thesupply 170 preferably has a cooling system (e.g., refrigerator, ice, etc.) that keeps the fluid 130 cool. Thesupply 170 preferably has a pumping mechanism or infuser pump for pushing the fluid 130 through thelumen 149 and theopening 144. - In some embodiments, shown in
FIG. 8 , thesupply 170 is in communication with thecontrol apparatus 164. Thesupply 170 receives a trigger or other control signal from thecontrol apparatus 164 which activates the pumping mechanism, and thereby causescool fluid 130 to be delivered through thecatheter opening 144. In another embodiment (not illustrated), thesupply 170 receives a control signal from a second control apparatus that is independent ofcontrol apparatus 164. The second control apparatus can comprise, for example, a button, switch, or peddle type of device that is controlled by the physician to initiate/stop the delivery ofcool fluid 130 through thecatheter lumen 149. - In accordance with one aspect of the embodiments described herein, there is provided a stroke treatment system comprising a flexible elongate catheter extending between a proximal end and a distal end, and a supply of cool fluid connected to the catheter proximal end. In some embodiments, the catheter is a small vessel catheter dimensioned for use in the vessels of the head and neck regions. In some embodiments, the stroke treatment system is similar to the system shown in
FIG. 8 , but lacks a balloon near the distal end of the catheter. - The methods and systems described herein relate to treating stroke. It will be noted, however, that these methods and systems can be adapted for the treatment of any number of medical conditions, such as, for example, focal contusions/hematomas associated with closed head injuries or the like. The methods and systems described herein can also be adapted for use in high-risk patients undergoing coronary artery bypass surgery. The methods and systems described herein can also be adapted for use in high-risk neurological procedures involving deep hypothermic arrest.
- While the present invention has been illustrated and described with particularity in terms of preferred embodiments, it should be understood that no limitation of the scope of the invention is intended thereby. Features of any of the foregoing methods and devices may be substituted or added into the others, as will be apparent to those of skill in the art. The scope of the invention is defined only by the claims appended hereto. It should also be understood that variations of the particular embodiments described herein incorporating the principles of the present invention will occur to those of ordinary skill in the art and yet be within the scope of the appended claims.
Claims (17)
1. A method of introducing fluid to a brain hemisphere in a mammal, the method comprising:
introducing a catheter assembly into an opening in a branch artery of the mammal's external carotid artery that is ipsilateral to the hemisphere;
advancing said catheter assembly from the opening in the branch artery along the branch artery in a direction retrograde to physiologic blood flow in the branch artery;
positioning an opening in said catheter assembly at or near the bifurcation of the mammal's internal and external carotid arteries that are ipsilateral to the hemisphere;
obstructing the external carotid artery at least partially; and
while at least partially obstructing the external carotid artery, introducing fluid through the opening in said catheter assembly such that the fluid flows into the mammal's ipsilateral internal carotid artery in a direction antegrade to physiologic blood flow in the ipsilateral internal carotid artery.
2. The method of claim 1 , wherein said fluid is cooler than body temperature.
3. The method of claim 1 , wherein said fluid has a temperature of about 0° C. to about 30° C.
4. The method of claim 3 , wherein said fluid has a temperature of about 5° C. to about 20° C.
5. The method of claim 1 , wherein the step of introducing fluid is performed during diastole of the mammal's cardiac cycle.
6. The method of claim 1 , wherein the catheter assembly comprises a counterpulsation balloon.
7. The method of claim 6 , wherein the step of temporarily occluding the external carotid artery comprises inflating the counterpulsation balloon.
8. The method of claim 7 , wherein the step of inflating the counterpulsation balloon is performed during diastole.
9. The method of claim 1 , wherein the fluid comprises a drug.
10. A method of introducing fluid to a brain hemisphere in a mammal, the method comprising:
introducing a catheter assembly into an opening in a branch artery of the mammal's external carotid artery that is ipsilateral to the hemisphere;
advancing said catheter assembly from the opening in the branch artery along the branch artery in a direction retrograde to physiologic blood flow;
positioning an opening in said catheter assembly within the external carotid artery; and
introducing fluid through the opening in said catheter assembly such that the fluid flows in the external carotid artery in a direction retrograde to physiologic blood flow and then flows into the mammal's ipsilateral internal carotid artery in a direction antegrade to physiologic blood flow.
11. A method for introducing fluid into a brain hemisphere in a mammal, the method comprising:
introducing a catheter assembly into an opening in a branch artery of the mammal's external carotid artery that is ipsilateral to the hemisphere;
advancing said catheter assembly from the opening in the branch artery along the branch artery in a direction retrograde to physiologic blood flow; and
introducing fluid through the opening in said catheter assembly such that the fluid flows into the mammal's ipsilateral internal carotid artery in a direction antegrade to physiologic blood flow.
12. A system for treating an ischemic organ, the system comprising:
a flexible, elongate catheter, the catheter having a proximal end and a distal end, the catheter comprising a lumen and a distal opening that is in communication with the lumen;
a counterpulsation balloon mounted at or near the catheter's distal end;
a controller in communication with the counterpulsation balloon, the controller configured to effect delivery of a quantity of a fluid through the catheter when the counterpulsation balloon is primarily in an inflation mode, the controller further configured to decrease or cease the delivery of the quantity of the fluid through the catheter when the counterpulsation balloon is primarily in a deflation mode.
13. The system of claim 12 , wherein the catheter is configured to be positioned in an external carotid artery of a human.
14. The system of claim 12 , further comprising a receptacle configured to supply the fluid to the catheter.
15. The system of claim 14 , further comprising a refrigeration system in thermal communication with the receptacle, the refrigeration system configured to keep the fluid below 30° C.
16. The system of claim 12 , wherein the controller is further configured to effect delivery repeatedly of quantities of fluid through the catheter during respective periods of inflation of the counterpulsation balloon, and the controller is further configured to cease or decrease delivery repeatedly of said quantities of fluid through the catheter during respective periods of deflation of the counterpulsation balloon.
17. A system for treating stroke in a patient, the system comprising:
first means for delivering fluid to an artery in the head of the patient;
second means for at least partially obstructing the artery, said second means being coupled to said first means;
third means for controlling delivery of a quantity of a fluid through the first means;
wherein said third means is in communication with said second means, such that said delivery of the fluid through the first means occurs when the second means is at least partially obstructing the artery, and said delivery of the fluid through the first means decreases or ceases when the second means is not at least partially obstructing the artery.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11/098,088 US20050228359A1 (en) | 2004-04-07 | 2005-04-04 | Method and apparatus for treating acute stroke |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US56020204P | 2004-04-07 | 2004-04-07 | |
US11/098,088 US20050228359A1 (en) | 2004-04-07 | 2005-04-04 | Method and apparatus for treating acute stroke |
Publications (1)
Publication Number | Publication Date |
---|---|
US20050228359A1 true US20050228359A1 (en) | 2005-10-13 |
Family
ID=35061536
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US11/098,088 Abandoned US20050228359A1 (en) | 2004-04-07 | 2005-04-04 | Method and apparatus for treating acute stroke |
Country Status (1)
Country | Link |
---|---|
US (1) | US20050228359A1 (en) |
Cited By (22)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20060167398A1 (en) * | 2005-01-25 | 2006-07-27 | Thermopeutix Inc. | System and methods for selective thermal treatment |
US20080221440A1 (en) * | 2007-03-08 | 2008-09-11 | Sync-Rx, Ltd. | Imaging and tools for use with moving organs |
US20100222671A1 (en) * | 2007-03-08 | 2010-09-02 | Sync-Rx, Ltd. | Identification and presentation of device-to-vessel relative motion |
US8700130B2 (en) | 2007-03-08 | 2014-04-15 | Sync-Rx, Ltd. | Stepwise advancement of a medical tool |
US8855744B2 (en) | 2008-11-18 | 2014-10-07 | Sync-Rx, Ltd. | Displaying a device within an endoluminal image stack |
US9095313B2 (en) | 2008-11-18 | 2015-08-04 | Sync-Rx, Ltd. | Accounting for non-uniform longitudinal motion during movement of an endoluminal imaging probe |
US9101286B2 (en) | 2008-11-18 | 2015-08-11 | Sync-Rx, Ltd. | Apparatus and methods for determining a dimension of a portion of a stack of endoluminal data points |
US9144394B2 (en) | 2008-11-18 | 2015-09-29 | Sync-Rx, Ltd. | Apparatus and methods for determining a plurality of local calibration factors for an image |
US9305334B2 (en) | 2007-03-08 | 2016-04-05 | Sync-Rx, Ltd. | Luminal background cleaning |
US9375164B2 (en) | 2007-03-08 | 2016-06-28 | Sync-Rx, Ltd. | Co-use of endoluminal data and extraluminal imaging |
US9629571B2 (en) | 2007-03-08 | 2017-04-25 | Sync-Rx, Ltd. | Co-use of endoluminal data and extraluminal imaging |
US9888969B2 (en) | 2007-03-08 | 2018-02-13 | Sync-Rx Ltd. | Automatic quantitative vessel analysis |
US9974509B2 (en) | 2008-11-18 | 2018-05-22 | Sync-Rx Ltd. | Image super enhancement |
US9999530B2 (en) | 2012-03-30 | 2018-06-19 | Elliot M. Gerber | Diastolic coronary stent deployment system for precise bifurcation lesion stenting |
US10362962B2 (en) | 2008-11-18 | 2019-07-30 | Synx-Rx, Ltd. | Accounting for skipped imaging locations during movement of an endoluminal imaging probe |
US10716528B2 (en) | 2007-03-08 | 2020-07-21 | Sync-Rx, Ltd. | Automatic display of previously-acquired endoluminal images |
US10748289B2 (en) | 2012-06-26 | 2020-08-18 | Sync-Rx, Ltd | Coregistration of endoluminal data points with values of a luminal-flow-related index |
WO2020251788A1 (en) | 2019-06-12 | 2020-12-17 | Walzman Daniel Ezra | Orientable intracranial occlusion device and method |
US11064964B2 (en) | 2007-03-08 | 2021-07-20 | Sync-Rx, Ltd | Determining a characteristic of a lumen by measuring velocity of a contrast agent |
US11064903B2 (en) | 2008-11-18 | 2021-07-20 | Sync-Rx, Ltd | Apparatus and methods for mapping a sequence of images to a roadmap image |
US11197651B2 (en) | 2007-03-08 | 2021-12-14 | Sync-Rx, Ltd. | Identification and presentation of device-to-vessel relative motion |
EP3982841A4 (en) * | 2019-06-12 | 2023-08-09 | Daniel Ezra Walzmann | Orientable intracranial occlusion device and method |
Citations (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3504674A (en) * | 1966-12-22 | 1970-04-07 | Emil S Swenson | Method and apparatus for performing hypothermia |
US5149321A (en) * | 1990-10-10 | 1992-09-22 | Klatz Ronald M | Brain resuscitation device and method for performing the same |
US5584804A (en) * | 1990-10-10 | 1996-12-17 | Life Resuscitation Technologies, Inc. | Brain resuscitation and organ preservation device and method for performing the same |
US5827222A (en) * | 1990-10-10 | 1998-10-27 | Life Resuscitation Technologies, Inc. | Method of treating at least one of brain and associated nervous tissue injury |
US6042559A (en) * | 1998-02-24 | 2000-03-28 | Innercool Therapies, Inc. | Insulated catheter for selective organ perfusion |
US6393320B2 (en) * | 1999-02-19 | 2002-05-21 | Alsius Corporation | Method for treating cardiac arrest |
US6436071B1 (en) * | 1999-06-08 | 2002-08-20 | The Trustees Of Columbia University In The City Of New York | Intravascular systems for corporeal cooling |
US6530945B1 (en) * | 2000-11-28 | 2003-03-11 | Alsius Corporation | System and method for controlling patient temperature |
US6547811B1 (en) * | 1999-08-02 | 2003-04-15 | Arch Development Corporation | Method for inducing hypothermia |
US6623514B1 (en) * | 2001-08-01 | 2003-09-23 | Origin Medsystems, Inc. | Method of cooling an organ |
US6626886B1 (en) * | 1999-04-07 | 2003-09-30 | Coaxia, Inc. | Devices and methods for preventing distal embolization during interventional procedures |
-
2005
- 2005-04-04 US US11/098,088 patent/US20050228359A1/en not_active Abandoned
Patent Citations (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3504674A (en) * | 1966-12-22 | 1970-04-07 | Emil S Swenson | Method and apparatus for performing hypothermia |
US5149321A (en) * | 1990-10-10 | 1992-09-22 | Klatz Ronald M | Brain resuscitation device and method for performing the same |
US5584804A (en) * | 1990-10-10 | 1996-12-17 | Life Resuscitation Technologies, Inc. | Brain resuscitation and organ preservation device and method for performing the same |
US5827222A (en) * | 1990-10-10 | 1998-10-27 | Life Resuscitation Technologies, Inc. | Method of treating at least one of brain and associated nervous tissue injury |
US6042559A (en) * | 1998-02-24 | 2000-03-28 | Innercool Therapies, Inc. | Insulated catheter for selective organ perfusion |
US6393320B2 (en) * | 1999-02-19 | 2002-05-21 | Alsius Corporation | Method for treating cardiac arrest |
US6626886B1 (en) * | 1999-04-07 | 2003-09-30 | Coaxia, Inc. | Devices and methods for preventing distal embolization during interventional procedures |
US6436071B1 (en) * | 1999-06-08 | 2002-08-20 | The Trustees Of Columbia University In The City Of New York | Intravascular systems for corporeal cooling |
US6605106B2 (en) * | 1999-06-08 | 2003-08-12 | The Trustees Of Columbia University In The City Of New York | Intravascular systems for corporeal cooling |
US6547811B1 (en) * | 1999-08-02 | 2003-04-15 | Arch Development Corporation | Method for inducing hypothermia |
US6530945B1 (en) * | 2000-11-28 | 2003-03-11 | Alsius Corporation | System and method for controlling patient temperature |
US6623514B1 (en) * | 2001-08-01 | 2003-09-23 | Origin Medsystems, Inc. | Method of cooling an organ |
Cited By (46)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7704220B2 (en) | 2005-01-25 | 2010-04-27 | Thermopeutix, Inc. | Systems and methods for selective thermal treatment |
US20060167398A1 (en) * | 2005-01-25 | 2006-07-27 | Thermopeutix Inc. | System and methods for selective thermal treatment |
US7789846B2 (en) | 2005-01-25 | 2010-09-07 | Thermopeutix, Inc. | System and methods for selective thermal treatment |
US9308052B2 (en) | 2007-03-08 | 2016-04-12 | Sync-Rx, Ltd. | Pre-deployment positioning of an implantable device within a moving organ |
US8290228B2 (en) | 2007-03-08 | 2012-10-16 | Sync-Rx, Ltd. | Location-sensitive cursor control and its use for vessel analysis |
US20080221439A1 (en) * | 2007-03-08 | 2008-09-11 | Sync-Rx, Ltd. | Tools for use with moving organs |
US9629571B2 (en) | 2007-03-08 | 2017-04-25 | Sync-Rx, Ltd. | Co-use of endoluminal data and extraluminal imaging |
US8463007B2 (en) | 2007-03-08 | 2013-06-11 | Sync-Rx, Ltd. | Automatic generation of a vascular skeleton |
US8542900B2 (en) | 2007-03-08 | 2013-09-24 | Sync-Rx Ltd. | Automatic reduction of interfering elements from an image stream of a moving organ |
US8670603B2 (en) | 2007-03-08 | 2014-03-11 | Sync-Rx, Ltd. | Apparatus and methods for masking a portion of a moving image stream |
US8693756B2 (en) | 2007-03-08 | 2014-04-08 | Sync-Rx, Ltd. | Automatic reduction of interfering elements from an image stream of a moving organ |
US8700130B2 (en) | 2007-03-08 | 2014-04-15 | Sync-Rx, Ltd. | Stepwise advancement of a medical tool |
US8781193B2 (en) | 2007-03-08 | 2014-07-15 | Sync-Rx, Ltd. | Automatic quantitative vessel analysis |
US9375164B2 (en) | 2007-03-08 | 2016-06-28 | Sync-Rx, Ltd. | Co-use of endoluminal data and extraluminal imaging |
US9008367B2 (en) | 2007-03-08 | 2015-04-14 | Sync-Rx, Ltd. | Apparatus and methods for reducing visibility of a periphery of an image stream |
US9008754B2 (en) | 2007-03-08 | 2015-04-14 | Sync-Rx, Ltd. | Automatic correction and utilization of a vascular roadmap comprising a tool |
US9014453B2 (en) | 2007-03-08 | 2015-04-21 | Sync-Rx, Ltd. | Automatic angiogram detection |
US11197651B2 (en) | 2007-03-08 | 2021-12-14 | Sync-Rx, Ltd. | Identification and presentation of device-to-vessel relative motion |
US9717415B2 (en) | 2007-03-08 | 2017-08-01 | Sync-Rx, Ltd. | Automatic quantitative vessel analysis at the location of an automatically-detected tool |
US11179038B2 (en) | 2007-03-08 | 2021-11-23 | Sync-Rx, Ltd | Automatic stabilization of a frames of image stream of a moving organ having intracardiac or intravascular tool in the organ that is displayed in movie format |
US9216065B2 (en) * | 2007-03-08 | 2015-12-22 | Sync-Rx, Ltd. | Forming and displaying a composite image |
US9305334B2 (en) | 2007-03-08 | 2016-04-05 | Sync-Rx, Ltd. | Luminal background cleaning |
US20080221440A1 (en) * | 2007-03-08 | 2008-09-11 | Sync-Rx, Ltd. | Imaging and tools for use with moving organs |
US11064964B2 (en) | 2007-03-08 | 2021-07-20 | Sync-Rx, Ltd | Determining a characteristic of a lumen by measuring velocity of a contrast agent |
US20100222671A1 (en) * | 2007-03-08 | 2010-09-02 | Sync-Rx, Ltd. | Identification and presentation of device-to-vessel relative motion |
US10716528B2 (en) | 2007-03-08 | 2020-07-21 | Sync-Rx, Ltd. | Automatic display of previously-acquired endoluminal images |
US9855384B2 (en) | 2007-03-08 | 2018-01-02 | Sync-Rx, Ltd. | Automatic enhancement of an image stream of a moving organ and displaying as a movie |
US9888969B2 (en) | 2007-03-08 | 2018-02-13 | Sync-Rx Ltd. | Automatic quantitative vessel analysis |
US9968256B2 (en) | 2007-03-08 | 2018-05-15 | Sync-Rx Ltd. | Automatic identification of a tool |
US10499814B2 (en) | 2007-03-08 | 2019-12-10 | Sync-Rx, Ltd. | Automatic generation and utilization of a vascular roadmap |
US10307061B2 (en) | 2007-03-08 | 2019-06-04 | Sync-Rx, Ltd. | Automatic tracking of a tool upon a vascular roadmap |
US10226178B2 (en) | 2007-03-08 | 2019-03-12 | Sync-Rx Ltd. | Automatic reduction of visibility of portions of an image |
US11064903B2 (en) | 2008-11-18 | 2021-07-20 | Sync-Rx, Ltd | Apparatus and methods for mapping a sequence of images to a roadmap image |
US9095313B2 (en) | 2008-11-18 | 2015-08-04 | Sync-Rx, Ltd. | Accounting for non-uniform longitudinal motion during movement of an endoluminal imaging probe |
US9974509B2 (en) | 2008-11-18 | 2018-05-22 | Sync-Rx Ltd. | Image super enhancement |
US9101286B2 (en) | 2008-11-18 | 2015-08-11 | Sync-Rx, Ltd. | Apparatus and methods for determining a dimension of a portion of a stack of endoluminal data points |
US11883149B2 (en) | 2008-11-18 | 2024-01-30 | Sync-Rx Ltd. | Apparatus and methods for mapping a sequence of images to a roadmap image |
US10362962B2 (en) | 2008-11-18 | 2019-07-30 | Synx-Rx, Ltd. | Accounting for skipped imaging locations during movement of an endoluminal imaging probe |
US9144394B2 (en) | 2008-11-18 | 2015-09-29 | Sync-Rx, Ltd. | Apparatus and methods for determining a plurality of local calibration factors for an image |
US8855744B2 (en) | 2008-11-18 | 2014-10-07 | Sync-Rx, Ltd. | Displaying a device within an endoluminal image stack |
US9999530B2 (en) | 2012-03-30 | 2018-06-19 | Elliot M. Gerber | Diastolic coronary stent deployment system for precise bifurcation lesion stenting |
US11051960B2 (en) | 2012-03-30 | 2021-07-06 | Gerber Elliot M | Control system for controlling the inflation of a balloon in a balloon stent catheter system |
US10748289B2 (en) | 2012-06-26 | 2020-08-18 | Sync-Rx, Ltd | Coregistration of endoluminal data points with values of a luminal-flow-related index |
US10984531B2 (en) | 2012-06-26 | 2021-04-20 | Sync-Rx, Ltd. | Determining a luminal-flow-related index using blood velocity determination |
EP3982841A4 (en) * | 2019-06-12 | 2023-08-09 | Daniel Ezra Walzmann | Orientable intracranial occlusion device and method |
WO2020251788A1 (en) | 2019-06-12 | 2020-12-17 | Walzman Daniel Ezra | Orientable intracranial occlusion device and method |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20050228359A1 (en) | Method and apparatus for treating acute stroke | |
US6726651B1 (en) | Method and apparatus for differentially perfusing a patient during cardiopulmonary bypass | |
US6435189B1 (en) | Methods and systems for treating ischemia | |
US6635046B1 (en) | Partial aortic occlusion devices and methods for cerebral perfusion augmentation | |
JP5074928B2 (en) | System for selective heat treatment | |
US6386202B1 (en) | Method for treating ischemic brain stroke | |
US11672643B2 (en) | Endovascular device with expandable filter | |
US20050004503A1 (en) | Method and apparatus for treating acute myocardial infarction with hypothermic perfusion | |
US6942686B1 (en) | Regulation of cerebral blood flow by temperature change-induced vasodilatation | |
WO1999038560A1 (en) | Methods and systems for treating ischemia | |
JP2010527269A (en) | System, method and apparatus for cerebral protection | |
WO2013012443A1 (en) | Novel approaches to venous occlusion for embolus management | |
LONGACRE et al. | Treatment of facial hemangioma by intravascular embolization with silicone spheres: case report | |
US20170333237A1 (en) | Vessel access catheter | |
US20190192830A1 (en) | Vessel access catheter | |
US20170333670A1 (en) | Vessel access catheter | |
JPH05504078A (en) | reperfusion device | |
Verdura et al. | Profound selective hypothermia and arrest of arterial circulation to the dog brain | |
CN115052651A (en) | Infusion catheter and method of use | |
WO2001078580A2 (en) | A method combining inducing hypothermia and administering a therapeutic agent | |
Mattingly et al. | Endovascular selective hypothermia facilitates giant aneurysm clipping: illustrative case | |
WO2015134864A2 (en) | Methods of reducing cerebral injury caused by embolic material | |
Loisance et al. | Hemopump for supported angioplasty |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |